ANNOUNCEMENT 19 Sep 2013

The Brazilian government-funded Company of Innovation and Research (FINEP) approved a loan of BRL 70.4 million to Biomm S.A.

NUMBER OF INTERVENTIONS

1

  • 1 harmful
  • 0 neutral
  • 0 liberalising

SOURCE

Brazilian Company of Innovation and Research. Empresa Brasileira de Inovaçao e Pesquisa. Projetos contratados e valores liberados. Retrieved on 02/05/2018. Available at: http://finep.gov.br/acesso-a-informacao-externo/transparencia/projetos-contratados-e-valores-liberados

Brazilian Company of Innovation and Research. Empresa Brasileira de Inovaçao e Pesquisa. Financiamento Reembolsável. Available at: http://finep.gov.br/component/content/article/120-apoio-e-financiamento/tipos-de-apoio/financiamento-reembolsavel/42-financiamento-reembolsavel

Inception date: 19 Sep 2013 | Removal date: 19 Sep 2019

State loan

On 19 September 2013, the Brazilian Company of Innovation and Research (FINEP) announced the approval of a loan of BRL 70.4 million (USD 31.9 million) allocated to Biomm S.A., a Brazilian-based company specialised in the development of biotechnological processes to produce active pharmaceutical ingredients. These resources will be allocated to the insulin project of the company.

The repayment deadline for the credit has been set to 19 September 2019.


FINEP lending
The resources enclosed on the programs managed by FINEP are limited to Brazilian companies and seek to boost the national and international competitiveness of these businesses.

The interest rates set on the credit lines are composed of the long-term interest rate (TJLP) plus a supplement ranging between 1.5% and 7%, depending on the credit line and the repayment period.

AFFECTED SECTORS

 

AFFECTED PRODUCTS